InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
4.230
-0.120 (-2.76%)
Nov 20, 2024, 4:00 PM EST - Market closed
InMed Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Nov '24 Nov 20, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Market Capitalization | 3 | 2 | 3 | 10 | 26 | 32 | |
| Market Cap Growth | 35.73% | -23.21% | -68.01% | -62.35% | -20.62% | -27.47% | |
| Enterprise Value | -2 | -4 | -6 | 5 | 16 | 26 | |
| Last Close Price | 4.23 | 5.31 | 18.53 | 235.20 | 1590.00 | 3088.80 | |
| PS Ratio | 0.42 | 0.52 | 0.75 | 8.85 | - | - | |
| PB Ratio | 0.34 | 0.26 | 0.26 | 1.06 | 3.47 | 5.49 | |
| P/TBV Ratio | 0.48 | 0.32 | 0.30 | 1.38 | 4.05 | 6.73 | |
| EV/Sales Ratio | - | - | - | 4.24 | - | - | |
| Debt / Equity Ratio | 0.13 | 0.10 | 0.03 | 0.09 | 0.04 | 0.05 | |
| Asset Turnover | 0.46 | 0.35 | 0.31 | 0.10 | - | - | |
| Inventory Turnover | 2.88 | 2.44 | 1.33 | - | - | - | |
| Quick Ratio | 4.12 | 3.53 | 4.61 | 1.90 | 3.35 | 3.52 | |
| Current Ratio | 5.07 | 4.41 | 5.66 | 2.89 | 3.78 | 3.77 | |
| Return on Equity (ROE) | -75.85% | -72.08% | -75.09% | -226.07% | -153.95% | -92.74% | |
| Return on Assets (ROA) | -42.47% | -39.21% | -38.94% | -75.28% | -70.65% | -51.18% | |
| Return on Capital (ROIC) | -46.99% | -44.89% | -46.85% | -96.98% | -89.75% | -58.38% | |
| Earnings Yield | -241.36% | -324.14% | -257.74% | -192.96% | -39.85% | -27.72% | |
| FCF Yield | -235.38% | -295.40% | -241.44% | -162.08% | -38.25% | -23.00% | |
| Buyback Yield / Dilution | -222.76% | -211.26% | -336.59% | -108.64% | -28.72% | -0.83% | |
| Total Shareholder Return | -222.76% | -211.26% | -336.59% | -108.64% | -28.72% | -0.83% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.